StockTipsArenaBeta

BUY Gland Pharma Limited — Shrikant Chouhan, Kotak Securities

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred Swing (≤2wk))10 Sept 2026via NDTV Profit

Entry₹3,031Inferred
Target₹3,200
Total upside +5.58% (call closed)
Stop loss₹2,850-5.97% risk
Exit₹2,85016 Sept 2026, 9:40 am
Stop-loss hit-5.97%
Follow Shrikant Chouhan for new calls(27% target hit, 110 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 1 active Swing call on GLANDSee 209 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 16 Sept 2026
5 supporting5 neutral2 opposing
Supports the BUY call (5)

Gland Pharma Ltd acquired Gland Pharma USA Inc., a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd.

BSE · Company Update·13 Sept · 2d ago

(opens in new tab)

Gland Pharma Limited's Board of Directors approved the acquisition of 100% equity share capital of Gland Pharma USA Inc., a step-down subsidiary, to streamline corporate structure. The acquisition is

BSE · Others·13 Sept · 2d ago

(opens in new tab)

5 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·7 Sept · 1w ago

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

NewsEt-Markets·3 Sept · 2w ago

(opens in new tab)

Gland Pharma Block Deal: Fosun Pharma to sell 5% stake at ₹2,763/share

NewsCnbc-Tv18·3 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (5)

Gland Pharma Limited's Board approved the acquisition of 100% equity share capital of Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd. This move aims to streamline the corporate structu

NSE · Outcome of Board Meeting·13 Sept · 2d ago

(opens in new tab)

Fosun Pharma sells 4.5% stake in Gland Pharma for Rs 2,121 crore

NewsHbl·5 Sept · 1w ago

(opens in new tab)

Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore

NewsEt-Markets·4 Sept · 2w ago

(opens in new tab)

Block deal alert! Gland Pharma shares in focus as promoter Fosun to sell 5% stake for Rs 2,279 crore

NewsEt-Markets·4 Sept · 2w ago

(opens in new tab)

Gland Pharma Promoter Likely To Sell 5% Stake Via Rs 2,279 Crore Block Deal

NewsNdtv-Profit·3 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (2)

Gland Pharma shares fall after ₹2,100 crore block deal; Promoter likely seller

NewsCnbc-Tv18·4 Sept · 2w ago

(opens in new tab)

Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

NewsEt-Markets·4 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome